Back to results
US 2003/0225077 A1Published application
Intermediate arylamine compounds
AssigneeBoehringer Ingelheim Pharmaceuticals, Inc.
InventorsPier F. Cirillo, Steffen Breitfelder, Usha R. Patel, John R. Proudfoot, Alan D. Swinamer
Life of this patent
Estimating the term…
Abstract
Disclosed are novel aromatic compounds which are useful for treating diseases or pathological conditions involving inflammation such as chronic inflammatory diseases. Also disclosed are and pharmaceutical compositions containing, intermediate compounds and processes of making such compounds.
Claims2
A compound chosen from:
- 56 57
A compound wherein the compound is:
- 58
Dependencies are inferred from the claim text.